MedPath

Validation of Apnea LinkTM for Sleep Apnea Syndrome Screening in a Bariatric Population

Terminated
Conditions
Sleep Apnea Syndrome
Registration Number
NCT01354756
Lead Sponsor
Centre Hospitalier Universitaire Saint Pierre
Brief Summary

Sleep apnea syndrome (OSA) frequently occurs in obese population undergoing bariatric surgery. There is a need for alternative screening tools for sleep apnea detection in the pre-operative period. The investigators would like to compare ApneaLink and complete polysomnography in this population.

Detailed Description

OSA can occur in up to 78% of patients undergoing bariatric surgery(1). Moderate to severe case will benefit from CPAP therapy, that can help avoiding post-operative complications(2).

In this population, the investigators propose complete attended in-hospital polysomnography (PSG)in patients with a clinical high probability of OSA.

According to obesity epidemics (3), waiting list for PSG in sleep labs is every day longer.

The investigators want to assess sensitivity and specificity of a new portable screening tool, ApneaLink, to detect OSA in a bariatric population.

Design:

monocentric and prospective study

Methods:

Patients:

- OSA suspicion based on :

* symptoms and signs (snoring, apneas , neck circumference \>38 (women) or 43cm (men))

* BMI \> 50

* BMI \> 40, \> 40 y

* BMI \> 35, men, hypertension

* increased serum Bicarbonate

* Polyglobulia

Measurements

* Polysomnography in sleep lab with concommitant recording performed with Apnea LinkTM (nasal flow and oxymétry recording).

* between 2 weeks : recording performed with Apnea LinkTM (nasal flow and oxymétry recording)at home.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • obese patients
  • > 18 years old
  • in whom a bariatric surgery is planified and who have to undergo a polysomnography for OSA screening
Exclusion Criteria
  • pulmonary, neurologic, neuromuscular disease
  • < 18 years old

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of patients with correct diagnosis of OSA with ApneaLink. Therefore, we will compare apnea-hypopnea index measured with ApneaLink with apnea-hypopnea index measured during polysomnography.2 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath